 | • レポートコード：MRC2-11QY08608 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はオキシトシン受容体拮抗薬のグローバル市場について調査・分析したレポートです。種類別（非ペプチド・経口活性オキシトシン受容体拮抗薬、高親和性ヒトオキシトシン（OT）受容体拮抗薬）市場規模、用途別（動物、人間）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別オキシトシン受容体拮抗薬の競争状況、市場シェア ・世界のオキシトシン受容体拮抗薬市場：種類別市場規模 2015年-2020年（非ペプチド・経口活性オキシトシン受容体拮抗薬、高親和性ヒトオキシトシン（OT）受容体拮抗薬） ・世界のオキシトシン受容体拮抗薬市場：種類別市場規模予測 2021年-2026年（非ペプチド・経口活性オキシトシン受容体拮抗薬、高親和性ヒトオキシトシン（OT）受容体拮抗薬） ・世界のオキシトシン受容体拮抗薬市場：用途別市場規模 2015年-2020年（動物、人間） ・世界のオキシトシン受容体拮抗薬市場：用途別市場規模予測 2021年-2026年（動物、人間） ・北米のオキシトシン受容体拮抗薬市場分析：米国、カナダ ・ヨーロッパのオキシトシン受容体拮抗薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのオキシトシン受容体拮抗薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のオキシトシン受容体拮抗薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのオキシトシン受容体拮抗薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Ferring、Sun Pharmaceutical、Biopas、PolyPeptide、CS Bio ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Oxytocin Receptor Antagonists Market
The global Oxytocin Receptor Antagonists market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Oxytocin Receptor Antagonists Scope and Market Size
Oxytocin Receptor Antagonists market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oxytocin Receptor Antagonists market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Oxytocin Receptor Antagonists market is segmented into
Non-Peptide and Orally Active Oxytocin Receptor Antagonist
High Affinity Human Oxytocin (OT) Receptor Antagonist
Segment by Application, the Oxytocin Receptor Antagonists market is segmented into
Animals
People
Regional and Country-level Analysis
The Oxytocin Receptor Antagonists market is analysed and market size information is provided by regions (countries).
The key regions covered in the Oxytocin Receptor Antagonists market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oxytocin Receptor Antagonists Market Share Analysis
Oxytocin Receptor Antagonists market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oxytocin Receptor Antagonists business, the date to enter into the Oxytocin Receptor Antagonists market, Oxytocin Receptor Antagonists product introduction, recent developments, etc.
The major vendors covered:
Ferring
Sun Pharmaceutical
Biopas
PolyPeptide
CS Bio
…
1 Study Coverage
1.1 Oxytocin Receptor Antagonists Product Introduction
1.2 Market Segments
1.3 Key Oxytocin Receptor Antagonists Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Oxytocin Receptor Antagonists Market Size Growth Rate by Type
1.4.2 Non-Peptide and Orally Active Oxytocin Receptor Antagonist
1.4.3 High Affinity Human Oxytocin (OT) Receptor Antagonist
1.5 Market by Application
1.5.1 Global Oxytocin Receptor Antagonists Market Size Growth Rate by Application
1.5.2 Animals
1.5.3 People
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Oxytocin Receptor Antagonists Market Size, Estimates and Forecasts
2.1.1 Global Oxytocin Receptor Antagonists Revenue 2015-2026
2.1.2 Global Oxytocin Receptor Antagonists Sales 2015-2026
2.2 Global Oxytocin Receptor Antagonists, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Oxytocin Receptor Antagonists Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Oxytocin Receptor Antagonists Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Oxytocin Receptor Antagonists Competitor Landscape by Players
3.1 Oxytocin Receptor Antagonists Sales by Manufacturers
3.1.1 Oxytocin Receptor Antagonists Sales by Manufacturers (2015-2020)
3.1.2 Oxytocin Receptor Antagonists Sales Market Share by Manufacturers (2015-2020)
3.2 Oxytocin Receptor Antagonists Revenue by Manufacturers
3.2.1 Oxytocin Receptor Antagonists Revenue by Manufacturers (2015-2020)
3.2.2 Oxytocin Receptor Antagonists Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Oxytocin Receptor Antagonists Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Oxytocin Receptor Antagonists Revenue in 2019
3.2.5 Global Oxytocin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Oxytocin Receptor Antagonists Price by Manufacturers
3.4 Oxytocin Receptor Antagonists Manufacturing Base Distribution, Product Types
3.4.1 Oxytocin Receptor Antagonists Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oxytocin Receptor Antagonists Product Type
3.4.3 Date of International Manufacturers Enter into Oxytocin Receptor Antagonists Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Oxytocin Receptor Antagonists Market Size by Type (2015-2020)
4.1.1 Global Oxytocin Receptor Antagonists Sales by Type (2015-2020)
4.1.2 Global Oxytocin Receptor Antagonists Revenue by Type (2015-2020)
4.1.3 Oxytocin Receptor Antagonists Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Oxytocin Receptor Antagonists Market Size Forecast by Type (2021-2026)
4.2.1 Global Oxytocin Receptor Antagonists Sales Forecast by Type (2021-2026)
4.2.2 Global Oxytocin Receptor Antagonists Revenue Forecast by Type (2021-2026)
4.2.3 Oxytocin Receptor Antagonists Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Oxytocin Receptor Antagonists Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Oxytocin Receptor Antagonists Market Size by Application (2015-2020)
5.1.1 Global Oxytocin Receptor Antagonists Sales by Application (2015-2020)
5.1.2 Global Oxytocin Receptor Antagonists Revenue by Application (2015-2020)
5.1.3 Oxytocin Receptor Antagonists Price by Application (2015-2020)
5.2 Oxytocin Receptor Antagonists Market Size Forecast by Application (2021-2026)
5.2.1 Global Oxytocin Receptor Antagonists Sales Forecast by Application (2021-2026)
5.2.2 Global Oxytocin Receptor Antagonists Revenue Forecast by Application (2021-2026)
5.2.3 Global Oxytocin Receptor Antagonists Price Forecast by Application (2021-2026)
6 North America
6.1 North America Oxytocin Receptor Antagonists by Country
6.1.1 North America Oxytocin Receptor Antagonists Sales by Country
6.1.2 North America Oxytocin Receptor Antagonists Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Oxytocin Receptor Antagonists Market Facts & Figures by Type
6.3 North America Oxytocin Receptor Antagonists Market Facts & Figures by Application
7 Europe
7.1 Europe Oxytocin Receptor Antagonists by Country
7.1.1 Europe Oxytocin Receptor Antagonists Sales by Country
7.1.2 Europe Oxytocin Receptor Antagonists Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oxytocin Receptor Antagonists Market Facts & Figures by Type
7.3 Europe Oxytocin Receptor Antagonists Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Oxytocin Receptor Antagonists by Region
8.1.1 Asia Pacific Oxytocin Receptor Antagonists Sales by Region
8.1.2 Asia Pacific Oxytocin Receptor Antagonists Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Oxytocin Receptor Antagonists Market Facts & Figures by Type
8.3 Asia Pacific Oxytocin Receptor Antagonists Market Facts & Figures by Application
9 Latin America
9.1 Latin America Oxytocin Receptor Antagonists by Country
9.1.1 Latin America Oxytocin Receptor Antagonists Sales by Country
9.1.2 Latin America Oxytocin Receptor Antagonists Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Oxytocin Receptor Antagonists Market Facts & Figures by Type
9.3 Central & South America Oxytocin Receptor Antagonists Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Oxytocin Receptor Antagonists by Country
10.1.1 Middle East and Africa Oxytocin Receptor Antagonists Sales by Country
10.1.2 Middle East and Africa Oxytocin Receptor Antagonists Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Oxytocin Receptor Antagonists Market Facts & Figures by Type
10.3 Middle East and Africa Oxytocin Receptor Antagonists Market Facts & Figures by Application
11 Company Profiles
11.1 Ferring
11.1.1 Ferring Corporation Information
11.1.2 Ferring Description and Business Overview
11.1.3 Ferring Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Ferring Oxytocin Receptor Antagonists Products Offered
11.1.5 Ferring Related Developments
11.2 Sun Pharmaceutical
11.2.1 Sun Pharmaceutical Corporation Information
11.2.2 Sun Pharmaceutical Description and Business Overview
11.2.3 Sun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sun Pharmaceutical Oxytocin Receptor Antagonists Products Offered
11.2.5 Sun Pharmaceutical Related Developments
11.3 Biopas
11.3.1 Biopas Corporation Information
11.3.2 Biopas Description and Business Overview
11.3.3 Biopas Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Biopas Oxytocin Receptor Antagonists Products Offered
11.3.5 Biopas Related Developments
11.4 PolyPeptide
11.4.1 PolyPeptide Corporation Information
11.4.2 PolyPeptide Description and Business Overview
11.4.3 PolyPeptide Sales, Revenue and Gross Margin (2015-2020)
11.4.4 PolyPeptide Oxytocin Receptor Antagonists Products Offered
11.4.5 PolyPeptide Related Developments
11.5 CS Bio
11.5.1 CS Bio Corporation Information
11.5.2 CS Bio Description and Business Overview
11.5.3 CS Bio Sales, Revenue and Gross Margin (2015-2020)
11.5.4 CS Bio Oxytocin Receptor Antagonists Products Offered
11.5.5 CS Bio Related Developments
11.1 Ferring
11.1.1 Ferring Corporation Information
11.1.2 Ferring Description and Business Overview
11.1.3 Ferring Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Ferring Oxytocin Receptor Antagonists Products Offered
11.1.5 Ferring Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Oxytocin Receptor Antagonists Market Estimates and Projections by Region
12.1.1 Global Oxytocin Receptor Antagonists Sales Forecast by Regions 2021-2026
12.1.2 Global Oxytocin Receptor Antagonists Revenue Forecast by Regions 2021-2026
12.2 North America Oxytocin Receptor Antagonists Market Size Forecast (2021-2026)
12.2.1 North America: Oxytocin Receptor Antagonists Sales Forecast (2021-2026)
12.2.2 North America: Oxytocin Receptor Antagonists Revenue Forecast (2021-2026)
12.2.3 North America: Oxytocin Receptor Antagonists Market Size Forecast by Country (2021-2026)
12.3 Europe Oxytocin Receptor Antagonists Market Size Forecast (2021-2026)
12.3.1 Europe: Oxytocin Receptor Antagonists Sales Forecast (2021-2026)
12.3.2 Europe: Oxytocin Receptor Antagonists Revenue Forecast (2021-2026)
12.3.3 Europe: Oxytocin Receptor Antagonists Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Oxytocin Receptor Antagonists Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Oxytocin Receptor Antagonists Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Oxytocin Receptor Antagonists Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Oxytocin Receptor Antagonists Market Size Forecast by Region (2021-2026)
12.5 Latin America Oxytocin Receptor Antagonists Market Size Forecast (2021-2026)
12.5.1 Latin America: Oxytocin Receptor Antagonists Sales Forecast (2021-2026)
12.5.2 Latin America: Oxytocin Receptor Antagonists Revenue Forecast (2021-2026)
12.5.3 Latin America: Oxytocin Receptor Antagonists Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Oxytocin Receptor Antagonists Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Oxytocin Receptor Antagonists Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Oxytocin Receptor Antagonists Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Oxytocin Receptor Antagonists Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Oxytocin Receptor Antagonists Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oxytocin Receptor Antagonists Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Oxytocin Receptor Antagonists Market Segments
Table 2. Ranking of Global Top Oxytocin Receptor Antagonists Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Oxytocin Receptor Antagonists Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Non-Peptide and Orally Active Oxytocin Receptor Antagonist
Table 5. Major Manufacturers of High Affinity Human Oxytocin (OT) Receptor Antagonist
Table 6. Global Oxytocin Receptor Antagonists Market Size Growth Rate by Application 2020-2026 (MT)
Table 7. Global Oxytocin Receptor Antagonists Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 8. Global Oxytocin Receptor Antagonists Sales by Regions 2015-2020 (MT)
Table 9. Global Oxytocin Receptor Antagonists Sales Market Share by Regions (2015-2020)
Table 10. Global Oxytocin Receptor Antagonists Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Oxytocin Receptor Antagonists Sales by Manufacturers (2015-2020) (MT)
Table 12. Global Oxytocin Receptor Antagonists Sales Share by Manufacturers (2015-2020)
Table 13. Global Oxytocin Receptor Antagonists Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Oxytocin Receptor Antagonists by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oxytocin Receptor Antagonists as of 2019)
Table 15. Oxytocin Receptor Antagonists Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Oxytocin Receptor Antagonists Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Oxytocin Receptor Antagonists Price (2015-2020) (USD/Kg)
Table 18. Oxytocin Receptor Antagonists Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Oxytocin Receptor Antagonists Product Type
Table 20. Date of International Manufacturers Enter into Oxytocin Receptor Antagonists Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Oxytocin Receptor Antagonists Sales by Type (2015-2020) (MT)
Table 23. Global Oxytocin Receptor Antagonists Sales Share by Type (2015-2020)
Table 24. Global Oxytocin Receptor Antagonists Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Oxytocin Receptor Antagonists Revenue Share by Type (2015-2020)
Table 26. Oxytocin Receptor Antagonists Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 27. Global Oxytocin Receptor Antagonists Sales by Application (2015-2020) (MT)
Table 28. Global Oxytocin Receptor Antagonists Sales Share by Application (2015-2020)
Table 29. North America Oxytocin Receptor Antagonists Sales by Country (2015-2020) (MT)
Table 30. North America Oxytocin Receptor Antagonists Sales Market Share by Country (2015-2020)
Table 31. North America Oxytocin Receptor Antagonists Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Oxytocin Receptor Antagonists Revenue Market Share by Country (2015-2020)
Table 33. North America Oxytocin Receptor Antagonists Sales by Type (2015-2020) (MT)
Table 34. North America Oxytocin Receptor Antagonists Sales Market Share by Type (2015-2020)
Table 35. North America Oxytocin Receptor Antagonists Sales by Application (2015-2020) (MT)
Table 36. North America Oxytocin Receptor Antagonists Sales Market Share by Application (2015-2020)
Table 37. Europe Oxytocin Receptor Antagonists Sales by Country (2015-2020) (MT)
Table 38. Europe Oxytocin Receptor Antagonists Sales Market Share by Country (2015-2020)
Table 39. Europe Oxytocin Receptor Antagonists Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Oxytocin Receptor Antagonists Revenue Market Share by Country (2015-2020)
Table 41. Europe Oxytocin Receptor Antagonists Sales by Type (2015-2020) (MT)
Table 42. Europe Oxytocin Receptor Antagonists Sales Market Share by Type (2015-2020)
Table 43. Europe Oxytocin Receptor Antagonists Sales by Application (2015-2020) (MT)
Table 44. Europe Oxytocin Receptor Antagonists Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Oxytocin Receptor Antagonists Sales by Region (2015-2020) (MT)
Table 46. Asia Pacific Oxytocin Receptor Antagonists Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Oxytocin Receptor Antagonists Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Oxytocin Receptor Antagonists Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Oxytocin Receptor Antagonists Sales by Type (2015-2020) (MT)
Table 50. Asia Pacific Oxytocin Receptor Antagonists Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Oxytocin Receptor Antagonists Sales by Application (2015-2020) (MT)
Table 52. Asia Pacific Oxytocin Receptor Antagonists Sales Market Share by Application (2015-2020)
Table 53. Latin America Oxytocin Receptor Antagonists Sales by Country (2015-2020) (MT)
Table 54. Latin America Oxytocin Receptor Antagonists Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Oxytocin Receptor Antagonists Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Oxytocin Receptor Antagonists Revenue Market Share by Country (2015-2020)
Table 57. Latin America Oxytocin Receptor Antagonists Sales by Type (2015-2020) (MT)
Table 58. Latin America Oxytocin Receptor Antagonists Sales Market Share by Type (2015-2020)
Table 59. Latin America Oxytocin Receptor Antagonists Sales by Application (2015-2020) (MT)
Table 60. Latin America Oxytocin Receptor Antagonists Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Oxytocin Receptor Antagonists Sales by Country (2015-2020) (MT)
Table 62. Middle East and Africa Oxytocin Receptor Antagonists Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Oxytocin Receptor Antagonists Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Oxytocin Receptor Antagonists Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Oxytocin Receptor Antagonists Sales by Type (2015-2020) (MT)
Table 66. Middle East and Africa Oxytocin Receptor Antagonists Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Oxytocin Receptor Antagonists Sales by Application (2015-2020) (MT)
Table 68. Middle East and Africa Oxytocin Receptor Antagonists Sales Market Share by Application (2015-2020)
Table 69. Ferring Corporation Information
Table 70. Ferring Description and Major Businesses
Table 71. Ferring Oxytocin Receptor Antagonists Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 72. Ferring Product
Table 73. Ferring Recent Development
Table 74. Sun Pharmaceutical Corporation Information
Table 75. Sun Pharmaceutical Description and Major Businesses
Table 76. Sun Pharmaceutical Oxytocin Receptor Antagonists Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 77. Sun Pharmaceutical Product
Table 78. Sun Pharmaceutical Recent Development
Table 79. Biopas Corporation Information
Table 80. Biopas Description and Major Businesses
Table 81. Biopas Oxytocin Receptor Antagonists Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 82. Biopas Product
Table 83. Biopas Recent Development
Table 84. PolyPeptide Corporation Information
Table 85. PolyPeptide Description and Major Businesses
Table 86. PolyPeptide Oxytocin Receptor Antagonists Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 87. PolyPeptide Product
Table 88. PolyPeptide Recent Development
Table 89. CS Bio Corporation Information
Table 90. CS Bio Description and Major Businesses
Table 91. CS Bio Oxytocin Receptor Antagonists Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 92. CS Bio Product
Table 93. CS Bio Recent Development
Table 94. Global Oxytocin Receptor Antagonists Sales Forecast by Regions (2021-2026) (MT)
Table 95. Global Oxytocin Receptor Antagonists Sales Market Share Forecast by Regions (2021-2026)
Table 96. Global Oxytocin Receptor Antagonists Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 97. Global Oxytocin Receptor Antagonists Revenue Market Share Forecast by Regions (2021-2026)
Table 98. North America: Oxytocin Receptor Antagonists Sales Forecast by Country (2021-2026) (MT)
Table 99. North America: Oxytocin Receptor Antagonists Revenue Forecast by Country (2021-2026) (US$ Million)
Table 100. Europe: Oxytocin Receptor Antagonists Sales Forecast by Country (2021-2026) (MT)
Table 101. Europe: Oxytocin Receptor Antagonists Revenue Forecast by Country (2021-2026) (US$ Million)
Table 102. Asia Pacific: Oxytocin Receptor Antagonists Sales Forecast by Region (2021-2026) (MT)
Table 103. Asia Pacific: Oxytocin Receptor Antagonists Revenue Forecast by Region (2021-2026) (US$ Million)
Table 104. Latin America: Oxytocin Receptor Antagonists Sales Forecast by Country (2021-2026) (MT)
Table 105. Latin America: Oxytocin Receptor Antagonists Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Middle East and Africa: Oxytocin Receptor Antagonists Sales Forecast by Country (2021-2026) (MT)
Table 107. Middle East and Africa: Oxytocin Receptor Antagonists Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 109. Key Challenges
Table 110. Market Risks
Table 111. Main Points Interviewed from Key Oxytocin Receptor Antagonists Players
Table 112. Oxytocin Receptor Antagonists Customers List
Table 113. Oxytocin Receptor Antagonists Distributors List
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Oxytocin Receptor Antagonists Product Picture
Figure 2. Global Oxytocin Receptor Antagonists Sales Market Share by Type in 2020 & 2026
Figure 3. Non-Peptide and Orally Active Oxytocin Receptor Antagonist Product Picture
Figure 4. High Affinity Human Oxytocin (OT) Receptor Antagonist Product Picture
Figure 5. Global Oxytocin Receptor Antagonists Sales Market Share by Application in 2020 & 2026
Figure 6. Animals
Figure 7. People
Figure 8. Oxytocin Receptor Antagonists Report Years Considered
Figure 9. Global Oxytocin Receptor Antagonists Market Size 2015-2026 (US$ Million)
Figure 10. Global Oxytocin Receptor Antagonists Sales 2015-2026 (MT)
Figure 11. Global Oxytocin Receptor Antagonists Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Oxytocin Receptor Antagonists Sales Market Share by Region (2015-2020)
Figure 13. Global Oxytocin Receptor Antagonists Sales Market Share by Region in 2019
Figure 14. Global Oxytocin Receptor Antagonists Revenue Market Share by Region (2015-2020)
Figure 15. Global Oxytocin Receptor Antagonists Revenue Market Share by Region in 2019
Figure 16. Global Oxytocin Receptor Antagonists Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Oxytocin Receptor Antagonists Revenue in 2019
Figure 18. Oxytocin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Oxytocin Receptor Antagonists Sales Market Share by Type (2015-2020)
Figure 20. Global Oxytocin Receptor Antagonists Sales Market Share by Type in 2019
Figure 21. Global Oxytocin Receptor Antagonists Revenue Market Share by Type (2015-2020)
Figure 22. Global Oxytocin Receptor Antagonists Revenue Market Share by Type in 2019
Figure 23. Global Oxytocin Receptor Antagonists Market Share by Price Range (2015-2020)
Figure 24. Global Oxytocin Receptor Antagonists Sales Market Share by Application (2015-2020)
Figure 25. Global Oxytocin Receptor Antagonists Sales Market Share by Application in 2019
Figure 26. Global Oxytocin Receptor Antagonists Revenue Market Share by Application (2015-2020)
Figure 27. Global Oxytocin Receptor Antagonists Revenue Market Share by Application in 2019
Figure 28. North America Oxytocin Receptor Antagonists Sales Growth Rate 2015-2020 (MT)
Figure 29. North America Oxytocin Receptor Antagonists Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Oxytocin Receptor Antagonists Sales Market Share by Country in 2019
Figure 31. North America Oxytocin Receptor Antagonists Revenue Market Share by Country in 2019
Figure 32. U.S. Oxytocin Receptor Antagonists Sales Growth Rate (2015-2020) (MT)
Figure 33. U.S. Oxytocin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Oxytocin Receptor Antagonists Sales Growth Rate (2015-2020) (MT)
Figure 35. Canada Oxytocin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Oxytocin Receptor Antagonists Market Share by Type in 2019
Figure 37. North America Oxytocin Receptor Antagonists Market Share by Application in 2019
Figure 38. Europe Oxytocin Receptor Antagonists Sales Growth Rate 2015-2020 (MT)
Figure 39. Europe Oxytocin Receptor Antagonists Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Oxytocin Receptor Antagonists Sales Market Share by Country in 2019
Figure 41. Europe Oxytocin Receptor Antagonists Revenue Market Share by Country in 2019
Figure 42. Germany Oxytocin Receptor Antagonists Sales Growth Rate (2015-2020) (MT)
Figure 43. Germany Oxytocin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Oxytocin Receptor Antagonists Sales Growth Rate (2015-2020) (MT)
Figure 45. France Oxytocin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Oxytocin Receptor Antagonists Sales Growth Rate (2015-2020) (MT)
Figure 47. U.K. Oxytocin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Oxytocin Receptor Antagonists Sales Growth Rate (2015-2020) (MT)
Figure 49. Italy Oxytocin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Oxytocin Receptor Antagonists Sales Growth Rate (2015-2020) (MT)
Figure 51. Russia Oxytocin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Oxytocin Receptor Antagonists Market Share by Type in 2019
Figure 53. Europe Oxytocin Receptor Antagonists Market Share by Application in 2019
Figure 54. Asia Pacific Oxytocin Receptor Antagonists Sales Growth Rate 2015-2020 (MT)
Figure 55. Asia Pacific Oxytocin Receptor Antagonists Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Oxytocin Receptor Antagonists Sales Market Share by Region in 2019
Figure 57. Asia Pacific Oxytocin Receptor Antagonists Revenue Market Share by Region in 2019
Figure 58. China Oxytocin Receptor Antagonists Sales Growth Rate (2015-2020) (MT)
Figure 59. China Oxytocin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Oxytocin Receptor Antagonists Sales Growth Rate (2015-2020) (MT)
Figure 61. Japan Oxytocin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Oxytocin Receptor Antagonists Sales Growth Rate (2015-2020) (MT)
Figure 63. South Korea Oxytocin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Oxytocin Receptor Antagonists Sales Growth Rate (2015-2020) (MT)
Figure 65. India Oxytocin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Oxytocin Receptor Antagonists Sales Growth Rate (2015-2020) (MT)
Figure 67. Australia Oxytocin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Oxytocin Receptor Antagonists Sales Growth Rate (2015-2020) (MT)
Figure 69. Taiwan Oxytocin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Oxytocin Receptor Antagonists Sales Growth Rate (2015-2020) (MT)
Figure 71. Indonesia Oxytocin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Oxytocin Receptor Antagonists Sales Growth Rate (2015-2020) (MT)
Figure 73. Thailand Oxytocin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Oxytocin Receptor Antagonists Sales Growth Rate (2015-2020) (MT)
Figure 75. Malaysia Oxytocin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Oxytocin Receptor Antagonists Sales Growth Rate (2015-2020) (MT)
Figure 77. Philippines Oxytocin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Oxytocin Receptor Antagonists Sales Growth Rate (2015-2020) (MT)
Figure 79. Vietnam Oxytocin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Oxytocin Receptor Antagonists Market Share by Type in 2019
Figure 81. Asia Pacific Oxytocin Receptor Antagonists Market Share by Application in 2019
Figure 82. Latin America Oxytocin Receptor Antagonists Sales Growth Rate 2015-2020 (MT)
Figure 83. Latin America Oxytocin Receptor Antagonists Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Oxytocin Receptor Antagonists Sales Market Share by Country in 2019
Figure 85. Latin America Oxytocin Receptor Antagonists Revenue Market Share by Country in 2019
Figure 86. Mexico Oxytocin Receptor Antagonists Sales Growth Rate (2015-2020) (MT)
Figure 87. Mexico Oxytocin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Oxytocin Receptor Antagonists Sales Growth Rate (2015-2020) (MT)
Figure 89. Brazil Oxytocin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Oxytocin Receptor Antagonists Sales Growth Rate (2015-2020) (MT)
Figure 91. Argentina Oxytocin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Oxytocin Receptor Antagonists Market Share by Type in 2019
Figure 93. Latin America Oxytocin Receptor Antagonists Market Share by Application in 2019
Figure 94. Middle East and Africa Oxytocin Receptor Antagonists Sales Growth Rate 2015-2020 (MT)
Figure 95. Middle East and Africa Oxytocin Receptor Antagonists Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Oxytocin Receptor Antagonists Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Oxytocin Receptor Antagonists Revenue Market Share by Country in 2019
Figure 98. Turkey Oxytocin Receptor Antagonists Sales Growth Rate (2015-2020) (MT)
Figure 99. Turkey Oxytocin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Oxytocin Receptor Antagonists Sales Growth Rate (2015-2020) (MT)
Figure 101. Saudi Arabia Oxytocin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Oxytocin Receptor Antagonists Sales Growth Rate (2015-2020) (MT)
Figure 103. U.A.E Oxytocin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Oxytocin Receptor Antagonists Market Share by Type in 2019
Figure 105. Middle East and Africa Oxytocin Receptor Antagonists Market Share by Application in 2019
Figure 106. North America Oxytocin Receptor Antagonists Sales Growth Rate Forecast (2021-2026) (MT)
Figure 107. North America Oxytocin Receptor Antagonists Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Oxytocin Receptor Antagonists Sales Growth Rate Forecast (2021-2026) (MT)
Figure 109. Europe Oxytocin Receptor Antagonists Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Oxytocin Receptor Antagonists Sales Growth Rate Forecast (2021-2026) (MT)
Figure 111. Asia Pacific Oxytocin Receptor Antagonists Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Oxytocin Receptor Antagonists Sales Growth Rate Forecast (2021-2026) (MT)
Figure 113. Latin America Oxytocin Receptor Antagonists Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Oxytocin Receptor Antagonists Sales Growth Rate Forecast (2021-2026) (MT)
Figure 115. Middle East and Africa Oxytocin Receptor Antagonists Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
N-ホルミルペプチド受容体2の世界市場（～2026年） Market Analysis and Insights: Global N-Formyl Peptide Receptor 2 Market The global N-Formyl Peptide Receptor 2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global N-Formyl Peptide Receptor 2 Scope and Market Size N-Formyl …- 低親和性免疫グロブリンガンマFc領域受容体II-bの世界市場（～2026年） Market Analysis and Insights: Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market The global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global…
- グルカゴン様ペプチド2受容体の世界市場（～2026年） Market Analysis and Insights: Global Glucagon Like Peptide 2 Receptor Market The global Glucagon Like Peptide 2 Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Glucagon Like Peptide 2 Receptor Scope and Market…
- カルシトニン遺伝子関連ペプチド1型受容体の世界市場（～2026年） Market Analysis and Insights: Global Calcitonin Gene Related Peptide Type 1 Receptor Market The global Calcitonin Gene Related Peptide Type 1 Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Calcitonin Gene Rel…
- ソマトスタチン受容体4型の世界市場（～2026年） Market Analysis and Insights: Global Somatostatin Receptor Type 4 Market The global Somatostatin Receptor Type 4 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Somatostatin Receptor Type 4 Scope and Market Size Somato…